TB-500 is a synthetic peptide fragment of thymosin beta-4, specifically the actin-binding tetrapeptide Ac-SDKP—a naturally occurring signaling molecule involved in cell migration and tissue repair. It is marketed almost entirely on recovery and injury-healing anecdotes in athlete and bodybuilding communities, but has never achieved FDA approval for any indication. WADA lists thymosin beta-4 and related fragments as prohibited substances in sport.

Safety note. This article is educational and for personal recordkeeping only. It gives no dose, unit count, concentration, reconstitution, injection technique, vendor, cycle, or stacking instructions. Peptide decisions, especially gray-market or research-use products, belong with a licensed professional.

What is TB-500?

TB-500 is a synthetic peptide based on a fragment of thymosin beta-4, a naturally occurring protein involved in cell repair and migration. Despite the recovery claims around it, TB-500 is not an FDA-approved medicine: it is sold as a research-use-only product, the FDA has flagged safety-information gaps for compounded versions, and the World Anti-Doping Agency prohibits it in sport.

Those facts come before any anecdote. A beginner may see TB-500 framed as a routine recovery tool, when its human evidence is limited and its status is both unapproved and banned in competition. For a broader safety frame, read Research Peptide Safety Questions Before You Start.

What do people use TB-500 for?

People most often mention TB-500 for soft-tissue recovery, joint comfort, training setbacks, and pairing with BPC-157 or GHK-Cu blends. Those are community claims, not proof. The same claim can mean very different things depending on whether it comes from a clinical label, a small trial, an animal model, a vendor page, or a forum anecdote.

Use the claim as a filing label, not a conclusion. Write down the purpose in plain language: what outcome is being watched, what else changed at the same time, and what would count as a reason to stop and ask for care.

How do people discuss using TB-500?

Reported use usually means research-use products, recovery stacks, and pre-mixed blends such as GLOW or KLOW-style combinations. The useful part to record is context, not numbers: why it was considered, who reviewed it, what else was already in the stack, and what stop signs were discussed.

Do not copy online calculators, vendor protocols, or preparation walkthroughs into a personal plan. A peptide protocol log should preserve professional guidance and observations, not turn a social post into instructions.

What does the research say?

FDA identifies thymosin beta-4 fragment, also known as TB-500, as having important safety information gaps for compounded human products. Community claims run far ahead of controlled human evidence.

A good research note separates mechanism, animal data, human trial data, approval status, and real-world anecdotes. When those buckets get mixed together, a peptide can look more proven than it is.

What should a beginner track?

Track the actual diagnosis, clinician instructions, pain and function changes, training load, imaging or therapy notes, and every question that needs professional follow-up.

In Dosefi, keep the entry boring and complete: date, category, source type, professional guidance, symptoms, photos only when useful, and the question you want answered next. A clear log is not proof that the peptide works. It is a way to avoid rewriting the story after the fact.

What red flags matter most?

Injury stories can be persuasive, but they can also delay diagnosis. Pain, swelling, impaired movement, fever, or worsening function needs medical evaluation rather than a peptide experiment.

Also pause when a product is sold only through anonymous vendors, when a blend hides individual ingredients, when the seller offers medical claims without medical oversight, or when the only evidence is a before-and-after post. Serious symptoms should be handled as health events, not as content to troubleshoot in comments.

Sources